Sport Lisboa e Benfica - Futebol, SAD (ELI:SLBEN)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 1, 2025	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	126	83	79	72	64	72
Market Cap Growth	-26.72%	5.22%	9.52%	12.50%	-10.26%	131.11%
Enterprise Value	322	262	219	190	196	208
Last Close Price	5.46	3.63	3.45	3.15	2.80	3.12
PE Ratio	3.53	19.82	-	-	1.54	2.44
PS Ratio	0.66	0.43	0.47	0.77	0.46	0.43
PB Ratio	-	0.74	0.73	0.50	0.40	0.62
P/TBV Ratio	-	-	-	-	10.56	-
EV/Sales Ratio	1.69	1.34	1.29	2.02	1.40	1.25
EV/EBITDA Ratio	-	-	-	-	-	20.16
EV/FCF Ratio	-5.41	-	-	-	-	-
Debt / Equity Ratio	-	1.50	1.57	1.01	0.62	1.27
Debt / EBITDA Ratio	-	-	-	-	-	14.31
Asset Turnover	-	0.36	0.32	0.19	0.28	0.34
Quick Ratio	-	0.69	0.61	0.45	0.50	0.57
Current Ratio	-	0.74	0.69	0.52	0.64	1.57
Return on Equity (ROE)	-	3.79%	-27.72%	-11.40%	30.08%	28.96%
Return on Assets (ROA)	-	-7.65%	-9.76%	-13.34%	-9.79%	-4.27%
Return on Capital (ROIC)	-	-14.83%	-18.09%	-24.50%	-18.44%	-7.98%
Earnings Yield	28.34%	5.05%	-44.13%	-23.99%	64.76%	40.96%
FCF Yield	-47.33%	-56.01%	-44.24%	-118.29%	-100.45%	-27.74%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.